← Eichor
Study identifier: NCT06939023 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)

Condition: Pancreatectomy · Distal Pancreatectomy (DP) · Pancreatic Neoplasms  ·  Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

PhaseNA
Planned participants256
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The DIPLOMA-3 trial is an international, multicenter, patient-blinded randomized controlled trial comparing laparoscopic and robot-assisted left-sided pancreatectomy. Patients with an indication for elective left-sided pancreatecomy for benign or premalignant lesions in the body or tail of the pancreas and considered eligible will be randomized between laparoscopic and robot-assisted resection.

This description comes directly from the study's public registry record.

Talk to the study team

Charlotte Baggerman van Houweninge, MD  ·  +31618037377  ·  c.e.baggermanvanhouweninge@amsterdamUMC.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Amsterdam UMCAmsterdam, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06939023